Goldman Sachs · 2021-11-09 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | +$815,088 | — | — | $18.9M | 每日估算 |
| 2026-07-30 | +$305,703 | — | — | $18.1M | 每日估算 |
| 2026-07-29 | -$90,876 | — | — | $18.0M | 每日估算 |
| 2026-07-28 | -$1.1M | — | — | $17.9M | 每日估算 |
| 2026-07-27 | -$7,400 | — | — | $18.9M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
LLY Eli Lilly & Co. COM | EC | 2,619 | $2.8M | 12.19% |
JNJ Johnson & Johnson COM | EC | 7,357 | $1.8M | 8.09% |
AZN AstraZeneca PLC ORD USD0.25 | EC | 6,923 | $1.4M | 6.40% |
MRK Merck & Co., Inc COM | EC |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified。
| 每日估算 |
| 2026-07-26 | +$1.0M | — | — | $18.9M | 每日估算 |
| 2026-07-25 | -$7,000 | — | — | $17.9M | 每日估算 |
| 2026-02-28 | +$1.9M | $1.9M | $0 | $22.6M | SEC 月度 |
| 2026-01-31 | $0 | $0 | $0 | — | SEC 月度 |
| 2025-12-31 | $0 | $0 | $0 | — | SEC 月度 |
| 10,915 |
| $1.4M |
| 5.98% |
BSX Boston Scientific Corporation COM | EC | 17,062 | $1.3M | 5.80% |
TMO Thermo Fisher Scientific Inc COM | EC | 2,001 | $1.0M | 4.61% |
ISRG Intuitive Surgical Inc. COM NEW | EC | 2,003 | $1.0M | 4.46% |
GH Guardant Health Inc COM | EC | 8,978 | $843,034 | 3.73% |
7741 HOYA Corp. NPV | EC | 4,523 | $818,848 | 3.62% |
ARGX Argenx SE SPONSORED ADR | EC | 1,061 | $813,702 | 3.60% |
COR Cencora Inc COM | EC | 2,056 | $765,120 | 3.38% |
ABT Abbott Laboratories COM | EC | 6,078 | $707,175 | 3.13% |
LONN Lonza Group AG CHF1 (REGD) | EC | 953 | $664,454 | 2.94% |
A Agilent Technologies Inc. COM | EC | 5,409 | $656,544 | 2.90% |
DXCM DexCom Inc COM | EC | 8,247 | $605,577 | 2.68% |
ROIV Roivant Sciences Ltd SHS | EC | 17,375 | $502,833 | 2.22% |
MTD Mettler-Toledo International Inc COM | EC | 293 | $400,440 | 1.77% |
APGE Apogee Therapeutics Inc. COM | EC | 5,225 | $365,750 | 1.62% |
DIM Sartorius Stedim Biotech SA EUR0.20 | EC | 1,658 | $358,437 | 1.59% |
IONS Ionis Pharmaceuticals, Inc. COM | EC | 3,918 | $317,946 | 1.41% |
QGEN QIAGEN NV ORD SHARES | EC | 6,309 | $314,188 | 1.39% |
RGEN Repligen Corporation COM | EC | 2,204 | $283,721 | 1.26% |
INSM Insmed Inc COM PAR $.01 | EC | 1,846 | $275,663 | 1.22% |
PEN Penumbra Inc. COM | EC | 750 | $258,293 | 1.14% |
FTOXX Goldman Sachs Financial Square Treasury Obligations Fund | STIV | 245,420 | $245,420 | 1.09% |
NTRA Natera Inc. COM | EC | 1,137 | $236,541 | 1.05% |
XENE Xenon Pharmaceuticals Inc COM | EC | 5,393 | $233,139 | 1.03% |
RPRX Royalty Pharma PLC COM USD0.0001 CLASS A | EC | 4,939 | $228,231 | 1.01% |
UNH UnitedHealth Group Inc. COM | EC | 775 | $227,284 | 1.01% |
CYTK Cytokinetics Inc COM NEW | EC | 3,546 | $220,632 | 0.98% |
BBIO Bridgebio Pharma Inc COM | EC | 3,115 | $207,085 | 0.92% |
MDGL Madrigal Pharmaceuticals Inc COM | EC | 466 | $201,312 | 0.89% |
RYTM Rhythm Pharmaceuticals Inc COM | EC | 2,150 | $199,370 | 0.88% |
CGON CG Oncology Inc. COM | EC | 3,187 | $187,396 | 0.83% |
ACLX Arcellx Inc COMMON STOCK | EC | 1,623 | $184,681 | 0.82% |
WGS GeneDx Holdings Corp COM CL A | EC | 1,664 | $132,637 | 0.59% |
RVMD Revolution Medicines Inc COM | EC | 1,159 | $118,241 | 0.52% |
PODD Insulet Corporation COM | EC | 432 | $106,536 | 0.47% |
RARE Ultragenyx Pharmaceuticals Inc COM | EC | 3,619 | $84,648 | 0.37% |
GPCR Structure Therapeutics Inc SPONSORED ADS | EC | 1,092 | $68,774 | 0.30% |